Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.
作者信息
Ostuni P, Botsios C, Punzi L, Sfriso P, Todesco S
出版信息
Ann Rheum Dis. 2003 Jul;62(7):686-7. doi: 10.1136/ard.62.7.686.
Abstract
摘要
相似文献
1
Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.在一名慢性乙型肝炎表面抗原携带者中，使用英夫利昔单抗和低剂量甲氨蝶呤治疗类风湿关节炎后发生乙型肝炎再激活。
Ann Rheum Dis. 2003 Jul;62(7):686-7. doi: 10.1136/ard.62.7.686.
2
Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.类风湿关节炎患者的乙型肝炎病毒再激活：日本国家数据库分析
J Viral Hepat. 2018 Nov;25(11):1312-1320. doi: 10.1111/jvh.12933. Epub 2018 Jun 13.
3
Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate.乙肝表面抗原阴性的类风湿关节炎患者在使用甲氨蝶呤治疗时乙肝病毒再激活。
Mod Rheumatol. 2012 Jun;22(3):470-3. doi: 10.1007/s10165-011-0521-9. Epub 2011 Sep 8.
4
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.HBV 核心抗体阳性的类风湿关节炎患者接受抗 TNF-α 治疗时病毒载量的动力学变化及乙型肝炎病毒再激活的风险。
Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.
5
Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.日本一项多中心、前瞻性、观察性研究：免疫抑制治疗风湿性疾病后已解决感染患者乙型肝炎病毒再激活的发生率。
Ann Rheum Dis. 2017 Jun;76(6):1051-1056. doi: 10.1136/annrheumdis-2016-209973. Epub 2016 Dec 1.
6
Fatal HBV reactivation in a subject with anti-HBs and anti-HBc.一名具有抗-HBs和抗-HBc的受试者发生致命性乙肝病毒再激活。
Intern Med. 2006;45(12):747-8. doi: 10.2169/internalmedicine.45.0158. Epub 2006 Jul 18.
7
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.英夫利昔单抗治疗克罗恩病患者后发生慢性乙型肝炎再激活：需要进行一级预防。
Gut. 2004 Sep;53(9):1363-5. doi: 10.1136/gut.2004.040675.
8
Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis.英夫利昔单抗治疗类风湿关节炎过程中与 Precore 突变乙型肝炎病毒相关的暴发性肝炎。
Clin Rheumatol. 2013 Mar;32 Suppl 1(Suppl 1):S47-9. doi: 10.1007/s10067-010-1438-y. Epub 2010 Apr 9.
9
Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.管理乙肝或丙肝感染患者的银屑病：实用注意事项。
Am J Clin Dermatol. 2019 Dec;20(6):829-845. doi: 10.1007/s40257-019-00457-3.
10
Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients.类风湿关节炎患者乙型肝炎病毒复制再激活的流行情况。
Mod Rheumatol. 2011 Feb;21(1):16-23. doi: 10.1007/s10165-010-0337-z. Epub 2010 Jul 29.
引用本文的文献
1
Hepatitis B reactivation risk and physician awareness in rheumatological patients receiving anti-tumor necrosis factor-α treatment.风湿性疾病患者接受抗肿瘤坏死因子-α治疗时乙型肝炎再激活的风险和医师认知。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(7):e20240091. doi: 10.1590/1806-9282.20240091. eCollection 2024.
2
Liver manifestations and complications in inflammatory bowel disease: A review.炎症性肠病的肝脏表现及并发症：综述
World J Hepatol. 2021 Dec 27;13(12):1956-1967. doi: 10.4254/wjh.v13.i12.1956.
3
Liver involvement in rheumatic diseases.肝脏在风湿性疾病中的受累情况。
Reumatologia. 2020;58(5):289-296. doi: 10.5114/reum.2020.99782. Epub 2020 Oct 13.
4
Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection.抗 TNF 治疗期间乙型肝炎再激活的风险；既往乙型肝炎感染患者的评估。
Turk J Gastroenterol. 2020 Jul;31(7):522-528. doi: 10.5152/tjg.2020.19295.
5
Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.生物制剂和检查点抑制剂所致肝损伤：一项系统文献综述
Hepatol Commun. 2020 Jan 2;4(2):172-184. doi: 10.1002/hep4.1465. eCollection 2020 Feb.
6
Methotrexate an Old Drug with New Tricks.甲氨蝶呤：老药新用
Int J Mol Sci. 2019 Oct 10;20(20):5023. doi: 10.3390/ijms20205023.
7
Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.抗 HBc 阳性的风湿性疾病患者采用改善病情抗风湿药物治疗的管理 - 2054 例患者的单中心分析。
Clin Rheumatol. 2018 Nov;37(11):2963-2970. doi: 10.1007/s10067-018-4295-8. Epub 2018 Sep 20.
8
Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: A multicenter countrywide study.类风湿关节炎和强直性脊柱炎中乙型和丙型肝炎感染的患病率：一项全国多中心研究。
Eur J Rheumatol. 2014 Jun;1(2):51-54. doi: 10.5152/eurjrheumatol.2014.018. Epub 2014 Jun 1.
9
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened.免疫抑制治疗或癌症化疗期间的乙肝再激活、管理与预防：一项全面综述——筛选版
Hepat Mon. 2016 Mar 26;16(4):e35810. doi: 10.5812/hepatmon.35810. eCollection 2016 Apr.
10
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.与抗风湿治疗相关的乙型肝炎病毒再激活：风险及预防建议。
World J Gastroenterol. 2015 Sep 28;21(36):10274-89. doi: 10.3748/wjg.v21.i36.10274.
Zotero 插件